Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 5
2005 4
2006 4
2007 8
2008 11
2009 10
2010 10
2011 12
2012 16
2013 6
2014 8
2015 11
2016 20
2017 10
2018 7
2019 1
2020 4
2021 2
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ; DECISION investigators. Brose MS, et al. Among authors: nutting cm. Lancet. 2014 Jul 26;384(9940):319-28. doi: 10.1016/S0140-6736(14)60421-9. Epub 2014 Apr 24. Lancet. 2014. PMID: 24768112 Free PMC article. Clinical Trial.
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, Boon C, Cook A, De Winton E, Emson M, Foran B, Frogley R, Petkar I, Pettit L, Rooney K, Roques T, Srinivasan D, Tyler J, Hall E; DARS Trialist Group. Nutting C, et al. Lancet Oncol. 2023 Aug;24(8):868-880. doi: 10.1016/S1470-2045(23)00265-6. Epub 2023 Jul 6. Lancet Oncol. 2023. PMID: 37423227 Free article. Clinical Trial.
Radiation-induced carotid artery atherosclerosis.
Gujral DM, Chahal N, Senior R, Harrington KJ, Nutting CM. Gujral DM, et al. Among authors: nutting cm. Radiother Oncol. 2014 Jan;110(1):31-8. doi: 10.1016/j.radonc.2013.08.009. Epub 2013 Sep 14. Radiother Oncol. 2014. PMID: 24044796 Review.
Stereotactic body radiotherapy for oligometastases.
Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ, van As NJ. Tree AC, et al. Among authors: nutting cm. Lancet Oncol. 2013 Jan;14(1):e28-37. doi: 10.1016/S1470-2045(12)70510-7. Lancet Oncol. 2013. PMID: 23276369 Review.
Treatment-related dysgeusia in head and neck cancer patients.
Irune E, Dwivedi RC, Nutting CM, Harrington KJ. Irune E, et al. Among authors: nutting cm. Cancer Treat Rev. 2014 Oct;40(9):1106-17. doi: 10.1016/j.ctrv.2014.06.011. Epub 2014 Jul 5. Cancer Treat Rev. 2014. PMID: 25064135 Review.
Primary orbital lymphoma.
Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN. Nutting CM, et al. Hematol J. 2002;3(1):14-6. doi: 10.1038/sj.thj.6200142. Hematol J. 2002. PMID: 11960390 Review. No abstract available.
140 results